Nuvation Bio Inc. (NUVB)
NYSE · Healthcare
Nuvation Bio Inc. Shareholder Equity 2023–2025
Nuvation Bio Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Nuvation Bio Inc. shareholder equity for the quarter ending December 31, 2025 were 305.7M, a 34.08% decrease year-over-year.
- Nuvation Bio Inc. shareholder equity for 2025 were 305.7M, a 34.08% decrease from 2024.
- Nuvation Bio Inc. shareholder equity for 2024 were 463.8M, a 23.36% decrease from 2023.
- Nuvation Bio Inc. shareholder equity for 2023 were 605.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Nuvation Bio Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $306 |
| 2024 | $464 |
| 2023 | $605 |
| Nuvation Bio Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $306 |
| 2024-12-31 | $464 |
| 2023-12-31 | $605 |
Nuvation Bio Inc. Shareholder Equity — FAQ
Nuvation Bio Inc. (NUVB) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NUVB's shareholder equity history?
The chart and table above show Nuvation Bio Inc.'s shareholder equity by year and by quarter, including the growth rate.